ADPTAdaptive Biotechnologies Corporation

$26.18

What is the market doing?

What the tape says about ADPT

Adaptive Biotechnologies Corporation is +109% over the past year while the S&P 500 is +23%: 86 points ahead of the market.

+109%

1-year return · S&P 500 +23%

vs 200-day average
+54%

vs 200-day average · a clear uptrend

RSI (14)
71

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
−0.29%

Below its 52-week high

2024-08-06$3.85 – $26.25 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$26.18
1 monthS&P 500 +3.7%
+17%
1 yearS&P 500 +23%
+109%
5 yearsS&P 500 +87%
−29%
vs 50-day average$21.30
+23%
52-week high
$26.25
52-week low
$12.15
Annualised volatility
76%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$15M
Calendar-year price return
YearReturn
2026 (year to date)+61%
2025+171%
2024+22%
2023−36%
2022−73%
2021−53%
2020+98%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan73 of 7−0.67%
Feb73 of 7−3.4%
Mar71 of 7−11%
Apr73 of 7−8.4%
May74 of 7+10%
Jun76 of 7+13%
Jul84 of 8+1.3%
Aug85 of 8+8.5%
Sep73 of 7−6.6%
Oct72 of 7−3.0%
Nov75 of 7+4.9%
Dec75 of 7+3.2%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.